SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013658
Filing Date
2023-05-10
Accepted
2023-05-10 17:01:42
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20230331_10q.htm   iXBRL 10-Q 1211073
2 EXHIBIT 31.1 ex_511849.htm EX-31.1 9200
3 EXHIBIT 31.2 ex_511850.htm EX-31.2 9206
4 EXHIBIT 32.1 ex_511851.htm EX-32.1 6055
  Complete submission text file 0001437749-23-013658.txt   5633607

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acrx-20230331.xsd EX-101.SCH 50730
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20230331_cal.xml EX-101.CAL 51786
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20230331_def.xml EX-101.DEF 364529
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20230331_lab.xml EX-101.LAB 339841
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20230331_pre.xml EX-101.PRE 384746
53 EXTRACTED XBRL INSTANCE DOCUMENT acrx20230331_10q_htm.xml XML 776404
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 23907508
SIC: 2834 Pharmaceutical Preparations